"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 7 | 1 | 8 |
| 1995 | 8 | 2 | 10 |
| 1996 | 17 | 3 | 20 |
| 1997 | 9 | 4 | 13 |
| 1998 | 17 | 1 | 18 |
| 1999 | 12 | 8 | 20 |
| 2000 | 14 | 4 | 18 |
| 2001 | 15 | 2 | 17 |
| 2002 | 16 | 6 | 22 |
| 2003 | 21 | 5 | 26 |
| 2004 | 18 | 1 | 19 |
| 2005 | 18 | 5 | 23 |
| 2006 | 26 | 3 | 29 |
| 2007 | 35 | 5 | 40 |
| 2008 | 38 | 4 | 42 |
| 2009 | 30 | 8 | 38 |
| 2010 | 48 | 7 | 55 |
| 2011 | 45 | 5 | 50 |
| 2012 | 39 | 3 | 42 |
| 2013 | 30 | 7 | 37 |
| 2014 | 30 | 3 | 33 |
| 2015 | 35 | 6 | 41 |
| 2016 | 34 | 3 | 37 |
| 2017 | 42 | 6 | 48 |
| 2018 | 32 | 5 | 37 |
| 2019 | 39 | 3 | 42 |
| 2020 | 33 | 3 | 36 |
| 2021 | 38 | 1 | 39 |
| 2022 | 54 | 2 | 56 |
| 2023 | 36 | 0 | 36 |
| 2024 | 32 | 6 | 38 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas. Neuro Oncol. 2024 Nov 04; 26(11):2044-2060.
-
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro Oncol. 2024 Oct 03; 26(10):1805-1822.
-
A brave new framework for glioma drug development. Lancet Oncol. 2024 Oct; 25(10):e512-e519.
-
EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner. Stem Cell Reports. 2024 10 08; 19(10):1516.
-
Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1299-1307.
-
Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma. Cancer Cell. 2024 Oct 14; 42(10):1713-1728.e6.
-
The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. AJR Am J Roentgenol. 2024 Oct; 223(4):e2431595.
-
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma. J Clin Invest. 2024 Aug 13; 134(19).
-
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology. Neuro Oncol. 2024 Aug 05; 26(8):1367-1387.
-
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro Oncol. 2024 Aug 05; 26(8):1509-1525.